Key takeaways:
Type 2 diabetes is a common condition that causes high blood sugar (glucose) levels. There are several medications that can help balance blood sugar.
Some diabetes medications are not considered first choices. While they can help lower blood sugar, they have higher risks for certain side effects. Examples of outdated diabetes medications include thiazolidinediones such as pioglitazone (Actos), sulfonylureas such as glipizide (Glucotrol XL), and meglitinides such as repaglinide.
First-choice medications for Type 2 diabetes work well to lower blood sugar and often have other benefits, such as heart or kidney protection. Examples include metformin and glucagon-like peptide-1 receptor agonists, such as Ozempic (semaglutide).
Type 2 diabetes is a health condition that causes high blood sugar (glucose). Over time, high blood sugar can lead to complications, such as nerve or kidney damage. For many people living with Type 2 diabetes, medication helps balance sugar levels and lower the risk of these long-term problems.
There are many medication options for managing Type 2 diabetes. What works for one person may not be right for someone else. But certain medications are less commonly prescribed than others. These medications often have a higher risk of serious side effects, such as low blood sugar (hypoglycemia).
So which medications aren’t a first choice for most people with Type 2 diabetes? Below, you’ll find information about four outdated diabetes medications.
Let's be clear: All Type 2 diabetes medications can be helpful, since they all lower blood sugar. But there are some that experts recommend trying first. Usually, first-choice medications work well to lower blood sugar and are less likely to cause serious side effects. Many of them also have other benefits, such as heart or kidney protection.
The American Diabetes Association recommends medications for diabetes based on these benefits. Outdated diabetes medications typically don’t have these benefits. And they tend to have a higher risk of certain side effects.
Still, an outdated medication is better than taking no medication at all. And your healthcare team may want you to take these medications for a specific reason. Everyone has a different situation. An outdated diabetes medication might be your best option for keeping your blood sugar in a healthy range.
Keep in mind: The outdated diabetes medications listed below typically cost less than newer medications. Cost is an important consideration when it comes to managing diabetes. Taking your medications as prescribed is key when it comes to balancing your blood sugar.
Thiazolidinediones (TZDs, or glitazones) are a class of oral diabetes medications. They help lower blood sugar by:
Making your body more sensitive to your natural insulin, which helps your body move sugar out of your bloodstream and into your cells
Lowering the amount of new sugar your liver makes
Protecting certain cells in your pancreas that make insulin
Pioglitazone (Actos) is the only TZD available in the U.S. It helps lower hemoglobin A1C (HbA1C or A1C) by about 1%. Your A1C represents your average blood sugar levels over the past 3 months. And pioglitazone is unlikely to cause low blood sugar.
But this medication can cause weight gain. And it can cause fluid buildup. This can worsen heart failure, a condition that’s commonly associated with diabetes. For these reasons, pioglitazone is usually not a first-choice medication for managing Type 2 diabetes.
Sulfonylureas are another class of oral Type 2 diabetes medications. They primarily work by causing your pancreas to release more insulin. This helps move sugar into your cells, lowering your blood sugar levels. Common sulfonylureas include:
Prevent long-term problems: Taking your diabetes medications as prescribed helps lower the risk of long-term complications, such as kidney damage.
Pills for diabetes: Read about which oral medications can treat Type 2 diabetes.
Future treatment options: Learn which diabetes medications are being studied and when they might be FDA approved.
Sulfonylureas are still commonly prescribed, even though they’re not first-choice medications. They can help lower A1C by up to 1.5%. They also have lower-cost generic versions available. But they have two notable side effects to consider.
Sulfonylureas have a higher risk of causing low blood sugar. This risk goes up if you’re also taking other diabetes medications. Sulfonylureas also tend to cause weight gain for many people.
Meglitinides (glinides) work similarly to sulfonylureas. But they don’t last as long in your body, so you’ll likely take more doses per day. Examples of glinides include repaglinide and nateglinide.
Glinides work about as well as sulfonylureas for lowering A1C. But they also have a risk of weight gain and low blood sugar. Glinides are less commonly prescribed because of these risks and because you have to take them more frequently.
Alpha glucosidase inhibitors are also oral diabetes medications. They work by slowing the absorption of carbohydrates from your small intestine. Examples of these medications include acarbose and miglitol (Glyset).
These medications are rarely used because of their side effects, such as gas and diarrhea. They also tend to provide less A1C reduction (about 0.5% to 1%) than some other options. Alpha glucosidase inhibitors usually work best for people who have high-carbohydrate diets. So if you’re following a low-carbohydrate diet, they may not work as well for you.
The following diabetes medications are some of the most effective for lowering blood sugar. Many also have other health benefits. This makes them common first-choice options for managing Type 2 diabetes.
Metformin belongs to the biguanide medication class. This oral medication helps lower blood sugar by:
Lowering how much new sugar your liver makes
Lowering how much sugar your body absorbs from foods and drinks
Helping your body use its natural insulin better
Metformin has been a long-standing first-choice medication for Type 2 diabetes. It works well, providing an average A1C reduction of 1% to 1.5%. It also has a low risk of causing low blood sugar.
What’s more, metformin doesn’t usually affect body weight and may help protect the heart. Most people experience only mild side effects, which improve after a few weeks. The risk of serious side effects with metformin is very low.
Glucagon-like peptide-1 (GLP-1) receptor agonists are popular diabetes medications. They work by acting like the natural gut hormone GLP-1. This has the following effects:
Triggers your pancreas to release insulin after you eat
Tells your liver to make less new sugar
Slows the passage of food through the gut, making you feel fuller for longer
Works in areas of the brain that balance appetite and food cravings
Popular GLP-1 receptor agonists include:
Ozempic (semaglutide)
Rybelsus (semaglutide) — an oral version of Ozempic
Trulicity (dulaglutide)
Mounjaro (tirzepatide) — both a GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
These medications work very well for lowering blood sugar (up to a 2% A1C reduction). They also can help people lose weight. For example, people using Ozempic in studies lost an average of 13 to 15 lbs after about 9 months.
Beyond blood sugar and weight loss benefits, some GLP-1 receptor agonists provide heart and kidney protection. They commonly cause digestive side effects, such as nausea, but these are generally mild. And they typically improve or stop with continued use.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are oral diabetes medications. They mainly work by removing extra sugar and sodium (salt) through your kidneys.
Popular SGLT2 inhibitors include:
These medications can help lower A1C by up to 1%. So you’ll likely add an SGLT2 inhibitor to existing diabetes medications, such as metformin, rather than take it by itself. And SGLT2 inhibitors may lead to modest weight loss for some people who take them.
Similar to GLP-1 receptor agonists, SGLT2 inhibitors have benefits beyond managing diabetes. Some can also help manage other conditions, such as chronic kidney disease or heart failure. In fact, you can take certain SGLT2 inhibitors for these conditions even if you don’t have diabetes.
Most people can take SGLT2 inhibitors without serious side effects. But they can cause you to pee more than usual, and they raise the risk of urinary tract infections and genital yeast infections.
There are many medications that can treat Type 2 diabetes. But experts recommend some diabetes medications over others.
Examples of outdated diabetes medications include thiazolidinediones such as pioglitazone (Actos), sulfonylureas such as glipizide (Glucotrol XL), and meglitinides such as repaglinide. These medications tend to have higher risks for certain side effects, such as low blood sugar.
First-choice diabetes medications work well and have a lower risk of serious side effects. They also often have other health benefits, such as heart or kidney protection. Preferred diabetes medications include metformin and glucagon-like peptide-1 receptor agonists such as Ozempic.
The best diabetes medication is different for everyone. What’s best for you will depend on your situation. Your healthcare team can help identify the right diabetes treatment for you.
Akmal, M., et al. (2024). Alpha glucosidase inhibitors. StatPearls.
American Diabetes Association Professional Practice Committee. (2025). 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes—2025. Diabetes Care.
ClinCalc.com. (n.d.). Glipizide: Drug usage statistics, United States, 2013-2022.
DeFilippis, E. M. (2023). Focus on heart failure | SGLT2 inhibitors in heart failure: The EMPEROR DELIVERs his SOLO. American College of Cardiology.
Feingold, K. R. (2024). Oral and injectable (non-insulin) pharmacological agents for the treatment of Type 2 diabetes. Endotext.
Frías, J. P., et al. (2021). Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): A double-blind, randomised, phase 3B trial. The Lancet Diabetes & Endocrinology.
Gorter, K. J., et al. (2014). Glycemic control in Type 2 diabetes (drug treatments). American Family Physician.
National Kidney Foundation. (2024). SGLT2 inhibitors.
Sanchez-Rangel, E., et al. (2017). Metformin: Clinical use in Type 2 diabetes. Diabetologia.
Schernthaner, G., et al. (2022). Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure. Metabolism.
Zurek, A. M., et al. (2017). A review of the efficacy and safety of sodium–glucose cotransporter 2 inhibitors: A focus on diabetic ketoacidosis. Diabetes Spectrum.